Literature DB >> 7604875

Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications.

B Criado1, A Barros, R F Suijkerbuijk, D O Weghuis, R Seruca, E Fonseca, S Castedo.   

Abstract

Polysomies of chromosomes 7 and 12 have been frequently observed by conventional cytogenetics in a subgroup of thyroid follicular adenomas and in some cases of thyroid goiters. To further study possible cytogenetic similarities between these two types of thyroid lesions, we have used fluorescence in situ hybridization (FISH) to detect polysomies of chromosomes 7 and/or 12 in isolated nuclei from frozen and paraffin-embedded material of goiters and thyroid follicular adenomas and compared results with previous ones obtained by flow cytometry and conventional cytogenetics. With a set of two alpha-satellite DNA probes specific for the centromeric regions of chromosomes 7 and 12, used either separately (single-target fluorescence in situ hybridization) or simultaneously (double-target fluorescence in situ hybridization), we detected polysomies of chromosome 7 in 35.7% of the thyroid follicular adenomas and in 10.7% of the goiters. Polysomies of chromosome 12 were detected in 29.6% of the thyroid follicular adenomas and 6.7% of the goiters. The significantly higher frequency of adenomas with numerical alterations for chromosomes 7 and/or 12 supports the idea of a biological continuum and karyotypic evolution between both lesions. It is also noteworthy that polysomies of chromosomes 7 and/or 12 were observed only in lesions with an exclusive (or predominant) microfollicular histological component, as detected by enzymatic in situ hybridization on frozen sections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7604875      PMCID: PMC1869887     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data.

Authors:  J R Teyssier; F Liautaud-Roger; D Ferre; M Patey; J Dufer
Journal:  Cancer Genet Cytogenet       Date:  1990-12

2.  Demonstration of the genuine iso-12p character of the standard marker chromosome of testicular germ cell tumors and identification of further chromosome 12 aberrations by competitive in situ hybridization.

Authors:  R F Suijkerbuijk; A Y van de Veen; J van Echten; C H Buys; B de Jong; J W Oosterhuis; D A Warburton; J J Cassiman; D Schonk; A Geurts van Kessel
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

3.  Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence.

Authors:  L H Looijenga; V T Smit; J W Wessels; P Mollevanger; J W Oosterhuis; C J Cornelisse; P Devilee
Journal:  Cytogenet Cell Genet       Date:  1990

4.  Genomic organization of alpha satellite DNA on human chromosome 7: evidence for two distinct alphoid domains on a single chromosome.

Authors:  J S Waye; S B England; H F Willard
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

5.  Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19).

Authors:  S Bartnitzke; M E Herrmann; H Lobeck; W Zuschneid; P Neuhaus; J Bullerdiek
Journal:  Cancer Genet Cytogenet       Date:  1989-05

6.  Cytogenetics of thyroid follicular adenomas.

Authors:  E van den Berg; J W Oosterhuis; B de Jong; J Buist; A Vos; A Dam; B Vermeij
Journal:  Cancer Genet Cytogenet       Date:  1990-02

7.  Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.

Authors:  A H Hopman; O Moesker; A W Smeets; R P Pauwels; G P Vooijs; F C Ramaekers
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

8.  High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.

Authors:  N R Lemoine; E S Mayall; F S Wyllie; E D Williams; M Goyns; B Stringer; D Wynford-Thomas
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

9.  Clonal composition of benign and malignant human thyroid tumors.

Authors:  H Namba; K Matsuo; J A Fagin
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

10.  Clonal analysis of solitary follicular nodules in the thyroid.

Authors:  D G Hicks; V A LiVolsi; J A Neidich; J M Puck; J A Kant
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

View more
  7 in total

1.  The Art and Applications of Fluorescence In Situ Hybridization in Endocrine Pathology.

Authors:  George Kontogeorgos
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

2.  FISHing chromosomes in endocrinology.

Authors:  G Kontogeorgos; K Kovacs
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

3.  Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.

Authors:  Brendan D Looyenga; Kyle A Furge; Karl J Dykema; Julie Koeman; Pamela J Swiatek; Thomas J Giordano; Andrew B West; James H Resau; Bin T Teh; Jeffrey P MacKeigan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  Numerical chromosome alterations in colorectal carcinomas detected by fluorescence in situ hybridization. Relationship to 17p and 18q allelic losses.

Authors:  A Ooi; C D Huang; M Mai; I Nakanishi
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

5.  Genomic differences in benign and malignant follicular thyroid tumours using 1-Mb array-comparative genomic hybridisation.

Authors:  Abdul A Qureshi; V P Collins; P Jani
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-13       Impact factor: 2.503

Review 6.  Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.

Authors:  G C Hard
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

7.  Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

Authors:  S Hemmer; V M Wasenius; S Knuutila; H Joensuu; K Franssila
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.